The Latest in AML

Iron chelating agent could enhance chemo in AML

December 28, 2017

FDA grants orphan designation to drug for AML

December 27, 2017

Health Canada approves midostaurin for AML

December 6, 2017

Drug receives fast track designation for FLT3+ rel/ref AML

December 2, 2017

Study reveals potential target for AML treatment

November 30, 2017

FDA grants drug orphan designation for AML, MDS

November 30, 2017

Study reveals predictor of early mortality in AML

November 28, 2017

Method identifies effective treatments for leukemias, lymphomas

November 22, 2017

Team discovers mechanism of resistance in AML

November 18, 2017

Rigosertib produces better OS in MDS than tAML

November 16, 2017

Generic azacitidine approved in Canada

November 16, 2017

EMA grants accelerated assessment to drug for AML

November 9, 2017

FDA lifts hold on trials of universal CAR T-cell therapy

November 8, 2017

Cancer drug costs increasing despite competition

November 6, 2017

Study reveals misperceptions among AML patients

November 2, 2017